Synagistics Limited has issued a circular outlining key resolutions for approval at its Annual General Meeting scheduled for 30 June 2026 in Singapore.

Share capital and authorisations • Current issued share capital: 459.89 million shares (no treasury shares). • Proposed general mandates: – Issue Mandate—Directors may allot and issue up to 20% of issued shares, equal to 91.98 million shares. – Buy-back Mandate—Authority to repurchase up to 10% of issued shares, or 45.99 million shares. – Extension Mandate—Shares repurchased under the Buy-back Mandate can be added to the Issue Mandate.

Board and auditor matters • Re-election: Executive Director & CEO Ms. Tai Ho Yan Olive and Independent Non-executive Director Mr. Andrew Chow Heng Cheong will retire by rotation and stand for re-election. • Auditor: Deloitte Touche Tohmatsu is proposed for re-appointment with an estimated FY 2026 audit fee of SGD 0.65 million.

Equity incentives • Proposed grant of 3.84 million restricted share units (RSUs) to CEO Ms. Tai, equal to 0.83% of issued shares. – Vesting: 50% on 30 June 2026 (AGM date) and 50% on 30 June 2027. – No exercise price; no performance targets. • Post-grant utilisation: Scheme mandate limit (originally 43.42 million shares) will fall to 26.22 million shares available for future awards.

Key dates • Register closure for AGM eligibility: 25–30 June 2026 (both days inclusive); last share transfer registration by 4:30 p.m. on 24 June 2026. • AGM: 30 June 2026, 9:30 a.m. (Singapore).

Voting arrangements All AGM resolutions will be decided by poll. Directors and related parties holding 17.51 million shares (3.81% stake) must abstain from voting on the RSU grant to Ms. Tai, which also requires independent shareholder approval due to exceeding 0.1% of issued share capital and the 1% individual limit under HKEX Listing Rules.